Business Update3 Jun 2026, 05:42 pm
Aurobindo Pharma Inaugurates Large-Scale Biologics Facility
AI Summary
Aurobindo Pharma has inaugurated TheraNym, a large-scale biologics contract manufacturing organization (CMO) in Telangana, India. The facility, a subsidiary of Aurobindo Pharma, aims to meet global demand for biologic therapies and has MSD as its anchor customer. The inauguration was attended by Telangana Ministers, highlighting the government's support for the life sciences industry. TheraNym is equipped with advanced manufacturing capabilities and is designed to meet international regulatory standards, positioning Aurobindo Pharma for growth in the biologics contract manufacturing segment.
Key Highlights
- Aurobindo Pharma launches TheraNym, a major biologics contract manufacturing facility.
- MSD is the anchor customer for the new TheraNym facility.
- The facility aims to serve global demand for biologic therapies.
- TheraNym is a subsidiary of Aurobindo Pharma, marking a strategic expansion.
- The launch signifies Aurobindo's commitment to the growing biologics market.
Price Impact
More from AUROPHARMA